Ieq Capital, LLC Bristol Myers Squibb CO Transaction History

Ieq Capital, LLC

$32.2 Billion
Q3 2025

A detailed history of Ieq Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ieq Capital, LLC holds 325,710 shares of BMY stock, worth $15.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

325,710

Previous 157,364 106.98%

Holding current value

$15.2 Million

Previous $7.28 Million 101.66%

% of portfolio

0.05%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$43.31 - $48.98 $7.29 Million - $8.25 Million	168,346 Added 106.98%	325,710 $14.7 Million
Q2 2025 Aug 14, 2025	SELL	$44.12 - $59.6 $668,815 - $903,476	-15,159 Reduced 8.79%	157,364 $7.28 Million
Q1 2025 May 14, 2025	BUY	$53.9 - $63.11 $2.01 Million - $2.36 Million	37,362 Added 27.64%	172,523 $10.5 Million
Q4 2024 Jan 31, 2025	BUY	$51.92 - $59.94 $2.02 Million - $2.33 Million	38,895 Added 40.4%	135,161 $7.64 Million
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $1.38 Million - $1.8 Million	34,739 Added 56.46%	96,266 $4.98 Million

Q2 2024 Aug 12, 2024	SELL	$40.25 - $52.99 $360,519 - $474,631	-8,957 Reduced 12.71%	61,527 $2.56 Million
Q1 2024 May 08, 2024	BUY	$47.98 - $54.4 $553,977 - $628,102	11,546 Added 19.59%	70,484 $3.82 Million
Q4 2023 Feb 07, 2024	SELL	$48.48 - $57.85 $220,826 - $263,506	-4,555 Reduced 7.17%	58,938 $3.02 Million
Q3 2023 Nov 03, 2023	SELL	$57.89 - $64.73 $862,676 - $964,606	-14,902 Reduced 19.01%	63,493 $3.69 Million
Q2 2023 Aug 07, 2023	BUY	$63.71 - $70.74 $32,046 - $35,582	503 Added 0.65%	78,395 $5.01 Million
Q1 2023 May 01, 2023	BUY	$65.71 - $74.53 $86,934 - $98,603	1,323 Added 1.73%	77,892 $5.4 Million
Q4 2022 Feb 03, 2023	BUY	$68.48 - $81.09 $786,766 - $931,643	11,489 Added 17.65%	76,569 $5.51 Million
Q3 2022 Nov 03, 2022	BUY	$0.13 - $76.84 $2,220 - $1.31 Million	17,077 Added 35.57%	65,080 $4.63 Million
Q2 2022 Jul 27, 2022	BUY	$72.62 - $79.98 $561,497 - $618,405	7,732 Added 19.2%	48,003 $3.7 Million
Q1 2022 Apr 26, 2022	BUY	$61.48 - $73.72 $469,461 - $562,925	7,636 Added 23.4%	40,271 $2.94 Million
Q4 2021 Jan 31, 2022	BUY	$53.63 - $62.52 $1,072 - $1,250	20 Added 0.06%	32,635 $2.04 Million
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $27,928 - $32,714	-472 Reduced 1.43%	32,615 $1.93 Million
Q2 2021 Jul 29, 2021	BUY	$61.91 - $67.42 $385,699 - $420,026	6,230 Added 23.2%	33,087 $2.21 Million
Q1 2021 May 04, 2021	BUY	$59.34 - $66.74 $181,758 - $204,424	3,063 Added 12.87%	26,857 $1.7 Million
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $82,972 - $94,022	1,437 Added 6.43%	23,794 $1.48 Million
Q3 2020 Nov 03, 2020	SELL	$57.43 - $63.64 $3,158 - $3,500	-55 Reduced 0.25%	22,357 $1.35 Million
Q2 2020 Jul 31, 2020	SELL	$54.82 - $64.09 $338,732 - $396,012	-6,179 Reduced 21.61%	22,412 $1.32 Million
Q1 2020 May 07, 2020	BUY	$46.4 - $67.43 $232,649 - $338,094	5,014 Added 21.27%	28,591 $1.59 Million
Q4 2019 Feb 11, 2020	SELL	$49.21 - $64.19 $155,700 - $203,097	-3,164 Reduced 11.83%	23,577 $1.51 Million
Q4 2019 Feb 04, 2020	BUY	$49.21 - $64.19 $1.32 Million - $1.72 Million	26,741 New	26,741 $1.22 Million

Others Institutions Holding BMY

# of Institutions

2,680

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.

Account